Skip to main content
Advanced Technical IVT

Sugammadex

Pronunciation: soo-GAM-ah-dex

A selective neuromuscular blocking reversal agent that rapidly reverses rocuronium and vecuronium.

Full Definition

Sugammadex is a modified γ-cyclodextrin that provides rapid and complete reversal of aminosteroid neuromuscular blocking agents (rocuronium and vecuronium) through molecular encapsulation. In obstetric anesthesia, it offers significant advantages by allowing rapid emergence from anesthesia regardless of the depth of neuromuscular blockade, which is particularly valuable in emergency situations or when immediate postoperative neurological assessment is required. Unlike traditional reversal agents (neostigmine), sugammadex doesn't require adequate spontaneous recovery and can reverse even deep neuromuscular blockade within 2-3 minutes. It has minimal side effects and doesn't interact with magnesium sulfate.

Usage

Usage note: Dose varies by depth of blockade (2-16 mg/kg); can reverse 'can't intubate, can't ventilate' situations.

In Context

  • "Sugammadex 4 mg/kg was administered to rapidly reverse deep neuromuscular blockade." — Reversal agent administration
  • "The ability to use sugammadex allowed for rocuronium use despite the need for rapid emergence." — Anesthetic technique justification

Also known as

Bridion

Don't confuse with

neostigmine pyridostigmine edrophonium

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON